Annexon, Inc. (ANNX) short interest & options flow
NASDAQAnnexon heads into Q3 with a striking split between insider conviction and persistent short seller pressure on a $4.13 stock that has lost 17% in a month. The most notable event this week is straightforward: CEO Douglas Love bought 26,065 shares in the open market on September 24 at $3.83, spending just under $100,000 of his own money. The purchase was not under a 10b5-1 plan…
ANNX short interest jumps 20.3% in one week to 16.4% of float, driven by recent clinical trial announcements and analyst coverage initiation.
- Market cap
- $796M
- Next earnings
- 12 Nov 2026
Key data as of 7 Nov 2026
Latest signals on ANNX
- Short Interest
ANNX short interest jumps 20.3% in one week to 16.4% of float, driven by recent clinical trial announcements and analyst coverage initiation.
ANNX news and analysis
RSSNo long-form analysis yet for ANNX. Pulse alerts and the live data picture are available on ORTEX.
Open ANNX on ORTEX →Want the live picture for ANNX?
Short interest updated daily, real-time options flow, analyst consensus deltas, 13F positioning, ORTEX Alpha signals, and every article ORTEX publishes for ANNX — free to start on ORTEX.
Sign up for free →Open ANNX on ORTEX